Skip to content

Seaport Therapeutics SPTX Change in Lease Liabilities

Change in Lease Liabilities at other companies

Repligen logo
RepligenRGEN
-$5.59M-15.7%
AppFolio logo
AppFolioAPPF
-$1.18M-12.3%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$547K-260%
Sunbelt Rentals Holdings
 logo
Sunbelt Rentals Holdings SUNB
-$179M-6.5%
Zillow Group, Inc. logo
Zillow Group, Inc.ZG
-$4M-100%
Procore Technologies logo
Procore TechnologiesPCOR
-$519K+33.5%

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's change in lease liabilities?
Seaport Therapeutics (SPTX) reported change in lease liabilities of -$323K in Q1 2026.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.